Research

We are an active participant in paediatric haematology research. As an ITCC early phase trials centre we offer a number of early phase trials including Delphinus (Daratumomab), ITCC-059 (Inotuzumab), PARC (recombinant arginase).Late phase trials active here include UKALL2011 and MyeChild. We also collaborate with basic science researchers at the University of Bristol and beyond, studying how to better understand the development of Leukaemia and its genetics. We offer all patients the opportunity to have samples of their Leukaemia entered into the Bloodwise Childhood Leukaemia Cellbank, the UKs primary resource for basic science research into Leukaemias.